Novartis Europharm Limited
SpainAll drugs from this manufacturer
-
It is used to treat postmenopausal women and men with a type of advanced breast cancer (hormone receptor-positive and epidermal growth factor receptor 2-negative) that has not responded to other hormonal treatments and presents mutations in the PIK3CA gene.
Dosage form: tablets, film-coated
Active substance Dosage alpelisib 200 mg -
It is used to treat postmenopausal women and men with a type of advanced breast cancer (hormone receptor-positive and HER2-negative) that has not responded to other hormonal treatments and that has PIK3CA gene mutations.
Dosage form: tablets, film-coated
Active substance Dosage alpelisib 50 mg alpelisib 200 mg -
It is used in adults with metastatic castration-resistant prostate cancer that has spread to other parts of the body and who have already received other cancer treatments, provided that the cancer cells have a protein called PSMA on their surface.
Dosage form: solution for injection and for infusion
Active substance Dosage lutetium (177lu) vipividotide tetraxetan 1000 MBq/ml -
It is used to help increase the number of platelets in the blood in cases of immune thrombocytopenia (primary) in patients over 1 year of age who have not responded to other treatments. It is also used to treat low platelet levels in adults with hepatitis C virus infection and in patients with severe aplastic anemia (SAA).
Dosage form: powder for preparation of oral suspension
Active substance Dosage eltrombopag 25 mg -
It is used to help increase the number of platelets in the blood in patients with immune thrombocytopenia (ITP), in adults with low platelet levels due to hepatitis C virus infection, and in patients with low blood cell counts caused by severe aplastic anemia (SAA).
Dosage form: tablets, film-coated
Active substance Dosage eltrombopag 25 mg -
It is used to help increase the number of platelets in the blood in cases of immune (primary) thrombocytopenia in patients over 1 year of age who have not responded to other treatments, to treat low platelet levels in adults with hepatitis C virus infection, and for patients with low blood cell counts due to severe aplastic anemia.
Dosage form: tablets, film-coated
Active substance Dosage eltrombopag 50 mg -
It is used to treat acute myeloid leukemia (AML) in adults with a FLT3 gene mutation. It is also used to treat aggressive systemic mastocytosis (ASM), systemic mastocytosis with an associated hematologic neoplasm (SM-AHN), or mast cell leukemia (MCL).
Dosage form: capsules, soft gelatin
Active substance Dosage midostaurin 25,00 mg -
It is used in adults to treat a type of blood cancer called chronic phase Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CP-CML).
Dosage form: tablets, film-coated
Active substance Dosage asciminib hydrochloride 21,620 mg -
It is used in adults to treat a type of blood cancer called chronic phase Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CP-CML).
Dosage form: tablets, film-coated
Active substance Dosage asciminib hydrochloride 43,24 mg -
It is used to help adults with chronic obstructive pulmonary disease (COPD) breathe. The medication blocks the contraction of the muscles surrounding the airways, making it easier for air to enter and exit.
Dosage form: powder for inhalation, hard capsule
Active substance Dosage glycopyrronium bromide 0,063 mg -
It is used to reduce pressure in the eyes of adult patients with glaucoma or ocular hypertension, especially when the pressure cannot be controlled with a single medication.
Dosage form: suspension, ophthalmic
Active substance Dosage brinzolamide 10 mg brimonidine tartrate 2 mg -
It is used in adults, adolescents, and children undergoing a kidney transplant to help prevent the body from rejecting the new organ during the first 4 to 6 weeks after surgery.
Dosage form: powder and solvent for solution for injection
Active substance Dosage basiliximab 20 mg -
It is used in children aged 1 year and older to treat a type of brain tumor called glioma (low or high grade), provided the tumor has a specific mutation in the BRAF gene. It must be used in conjunction with another medication called dabrafenib.
Dosage form: powder for oral solution
Active substance Dosage trametinib dimethyl sulfoxide 5,3 mg -
It is used to treat adults with a type of advanced or metastatic non-small cell lung cancer (NSCLC), provided that the cancer is caused by a mutation in the gene that produces the MET enzyme.
Dosage form: tablets, film-coated
Active substance Dosage capmatinib dihydrochloride monohydrate 183 mg -
It is used to treat adult patients with a type of non-small cell lung cancer (NSCLC) that is advanced or has spread to other parts of the body, provided that the cancer is caused by a mutation in a gene that produces the MET enzyme.
Dosage form: tablets, film-coated
Active substance Dosage capmatinib dihydrochloride monohydrate 244 mg -
It is used in adults to treat a type of skin cancer called melanoma that has spread to other parts of the body or cannot be removed by surgery. It can also be used to prevent melanoma from reappearing after surgery. Additionally, in combination with trametinib, it is used to treat a type of non-small cell lung cancer (NSCLC).
Dosage form: capsules, hard
Active substance Dosage dabrafenib mesilate 59,25 mg -
It is used in adults to treat a type of skin cancer called melanoma that has spread to other parts of the body or cannot be removed by surgery. It can also be used to prevent melanoma from reappearing after surgery. Additionally, in combination with trametinib, it is used to treat a type of non-small cell lung cancer (NSCLC).
Dosage form: capsules, hard
Active substance Dosage dabrafenib mesilate 88,88 mg -
It is used to treat a type of blood cancer called Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in adults and children, either upon new diagnosis or when other treatments have not worked or have caused serious side effects.
Dosage form: capsules, hard
Active substance Dosage nilotinib 150 mg -
It is used to treat a type of blood cancer called Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in adults and children, either as a new diagnosis or when other treatments have not worked or have caused serious side effects.
Dosage form: capsules, hard
Active substance Dosage nilotinib 200 mg -
It is used to make breathing easier in adults with chronic obstructive pulmonary disease (COPD), helping the airway muscles not to tighten and allowing air to enter and leave the lungs more effectively.
Dosage form: powder for inhalation, hard capsule
Active substance Dosage glycopyrronium bromide 0,063 mg -
It is used to reduce elevated pressure in the eye in adults, adolescents, and children from 2 months of age, a condition that can lead to glaucoma.
Dosage form: solution, ophthalmic
Active substance Dosage travoprost 40 µg -
It is used to treat certain types of advanced or metastatic breast cancer (cancer that has spread beyond the original tumor or to other organs) that overexpress HER2 receptors. It is prescribed in combination with other anticancer medicines.
Dosage form: tablets, chewable
Active substance Dosage lapatinib 250 mg -
It is used to make breathing easier in adults with chronic obstructive pulmonary disease (COPD), helping to prevent the airway muscles from tightening so that air can move in and out more easily.
Dosage form: powder for inhalation, hard capsule
Active substance Dosage indacaterol maleate 0,143 mg glycopyrronium bromide 0,063 mg -
It is used to make breathing easier in adults with chronic obstructive pulmonary disease (COPD). It helps prevent the airway muscles from tightening, allowing air to enter and leave the lungs more easily.
Dosage form: powder for inhalation, hard capsule
Active substance Dosage indacaterol maleate 0,143 mg glycopyrronium bromide 0,063 mg -
It is used in adults to treat advanced kidney cancer or cancer that has spread to other organs, as well as certain types of soft tissue sarcoma.
Dosage form: tablets, film-coated
Active substance Dosage pazopanib hydrochloride 200 mg -
It is used in adults to treat advanced kidney cancer or cancer that has spread to other organs, as well as certain types of soft tissue sarcoma.
Dosage form: tablets, film-coated
Active substance Dosage pazopanib hydrochloride 400 mg -
It is used to treat certain kidney tumors (renal angiomyolipomas) and brain tumors (SEGA) in adults and children, caused by a genetic disorder called tuberous sclerosis complex (TSC).
Dosage form: tablets
Active substance Dosage everolimus 10,00 mg -
It is used to treat certain kidney tumors (renal angiomyolipomas) and brain tumors (subependymal giant cell astrocytomas or SEGA) in adults and children, caused by a genetic disorder called tuberous sclerosis complex (TSC).
Dosage form: tablets, dispersible
Active substance Dosage everolimus 2 mg -
It is used to treat kidney tumors (renal angiomyolipomas) and brain tumors (subependymal giant cell astrocytomas or SEGA) in people with a genetic disorder called tuberous sclerosis complex (TSC).
Dosage form: tablets
Active substance Dosage everolimus 2,5 mg -
It is used to treat kidney tumors (renal angiomyolipomas) and brain tumors (subependymal giant cell astrocytomas or SEGA) in adults and children, caused by a genetic disorder called tuberous sclerosis complex (TSC).
Dosage form: tablets, dispersible
Active substance Dosage everolimus 3 mg -
It is used to treat certain kidney tumors (renal angiomyolipomas) and brain tumors (subependymal giant cell astrocytomas or SEGA) in adults and children, caused by a genetic disorder called tuberous sclerosis complex (TSC).
Dosage form: tablets, dispersible
Active substance Dosage everolimus 5 mg -
It is used to treat kidney tumors (renal angiomyolipomas) and brain tumors (SEGA) in adults and children who have a genetic disorder called tuberous sclerosis complex (TSC).
Dosage form: tablets
Active substance Dosage everolimus 5 mg -
It is used to treat adults with type 2 diabetes when diet and exercise are not enough to control blood sugar levels.
Dosage form: tablets
Active substance Dosage vildagliptin 50 mg -
It is used to treat adult patients with type 2 diabetes when diet and exercise are not sufficient to control blood sugar levels.
Dosage form: tablets
Active substance Dosage vildagliptin 50 mg -
It is used for the treatment of severe allergic asthma in adults and children (from 6 years of age), chronic rhinosinusitis with nasal polyps in adults (from 18 years of age), and chronic spontaneous urticaria in adults and adolescents (from 12 years of age).
Dosage form: solution for injection in a pre-filled syringe
Active substance Dosage omalizumab 150 mg -
It is used for the treatment of severe allergic asthma in adults, adolescents, and children aged 6 years and older whose symptoms are not controlled with other medications. It is also used in adults (over 18 years old) to treat chronic rhinosinusitis with nasal polyps.
Dosage form: solution for injection in a pre-filled syringe
Active substance Dosage omalizumab 75 mg -
It is used to make breathing easier in adults with chronic obstructive pulmonary disease (COPD). It helps prevent the airway muscles from tightening, allowing air to enter and leave the lungs more easily.
Dosage form: powder for inhalation, hard capsule
Active substance Dosage indacaterol maleate 0,143 mg glycopyrronium bromide 0,063 mg -
It is used as a regular treatment for asthma in adults. It helps to open the airways and reduce inflammation in the lungs.
Dosage form: powder for inhalation, hard capsule
Active substance Dosage indacaterol acetate 0,173 mg glycopyrronium bromide 0,063 mg mometazone furoate 0,1600 mg -
It is used to treat spinal muscular atrophy (SMA), which is a serious and rare hereditary disease.
Dosage form: solution for infusion
Active substance Dosage onasemnogen abeparvovec 2 x 10e13 Genoma vectorial -
It is used to treat adult patients with type 2 diabetes when it cannot be controlled by diet and exercise alone, or when the use of other medications such as insulin or sulfonylureas is insufficient.
Dosage form: tablets, film-coated
Active substance Dosage metformin hydrochloride 1000 mg vildagliptin 50 mg -
It is used to treat adult patients with type 2 diabetes when the disease cannot be controlled by diet and exercise alone, or with other medications such as insulin or sulfonylureas.
Dosage form: tablets, film-coated
Active substance Dosage metformin hydrochloride 850 mg vildagliptin 50 mg -
It is used to treat adult patients with advanced stages of a type of lung cancer called non-small cell lung cancer (NSCLC), provided the disease is caused by a defect in the ALK gene.
Dosage form: capsules, hard
Active substance Dosage ceritinib 150 mg